Hepatitis C, Transarterial Embolization Versus Symptomatic Treatment in Patients With Advanced Hepatocellular Carcinoma, Current Information On Hepatitis C & treatments for the medical professional and patient.

Transarterial Embolization Versus Symptomatic Treatment in Patients
With Advanced Hepatocellular Carcinoma:
Results of a Randomized, Controlled Trial in a Single Institution

	table 3.
Probability of Survival of the Patients According to Their Baseline Characteristics

Baseline Characteristic	Probability of Survival			P
Baseline Characteristic	2 yr	4 yr	Median (mo)	P

Child-Pugh’s class A
TAE (35)	56%	15%	27
Control (31)	52%	27%	25	0.95
Child-Pugh’s class B
TAE (5)	0%	0%	7
Control (9)	44%		13	0.46
Okuda’s stage I
TAE (27)	59%	15%	28
Control (27)	56%	31%	26	0.64
Okuda’s stage II
TAE (13)	27%	13%	13
Control (13)	38%		13	0.69
Performance status 0
TAE (27)	62%	18%	29
Control (27)	63%	36%	29	0.91
Performance status 1
TAE (11)	27%	0%	9
Control (11)	27%		18	0.67

[Return To Article]

Hepatitis C, Transarterial Embolization Versus Symptomatic Treatment in Patients With Advanced Hepatocellular Carcinoma, Current Information On Hepatitis C & treatments for the medical professional and patient.

Share

Follow Us

Download Our Free Reports

Inside You'll Discover:

Thank You!